Close

BIO Encouraged By House GOP Drug Benefit Plan

Apr 12 2000
WASHINGTON, D.C., (April 12, 2000) Nancy Bradish Myers, health-care policy and reimbursement counsel for the Biotechnology Industry Organization (BIO), issued the following statement concerning...

BIO Statement Regarding National Research Council Press Release on Genetically Modified Plants

Apr 5 2000
(Dr. Val Giddings, vice president for food and agriculture of the Biotechnology Industry Organization (BIO) today made the following comments in response to the National Research Council (NRC)...

BIO Supports Findings of National Research Council Report Regarding Genetically Modified Plants

Apr 5 2000
WASHINGTON (April 5, 2000) Recommendations put forth today in a National Research Council report entitled Genetically Modified Pest Protected Plants: Science and Regulation are well-founded in...

BIO Praises Clinton Reassurances Regarding Gene Patents and PTO Leadership

Apr 5 2000
WASHINGTON, D.C. (April 5, 2000) The Biotechnology Industry Organization (BIO) applauded President Clinton for comments today clarifying his March 14 joint statement with British Prime Minister...

BIO Elects Board Members, Officers for 2000-2001

Apr 4 2000
WASHINGTON (April 3, 2000) The Biotechnology Industry Organization (BIO) today announced as chairman of the board of directors, Mark Skaletsky, president and CEO of GelTex Pharmaceuticals Inc., of...

BIO Response to Reps. Kucinich and Metcalf Regarding National Academy of Sciences Report

Apr 4 2000
(Carl B. Feldbaum, president of BIO, today issued the following statement regarding a request by Reps. Dennis Kucinich (D-Ohio) and Jack Metcalf (R-Wash.) to the National Academy of Sciences to...

PUBLIC INFORMATION PROGRAM ON BIOTECHNOLOGY BEGINS APRIL 3

Apr 3 2000
Washington - April 3, 2000 - A multi-year, industry-led public information program begins today to share information about agricultural biotechnology with people in the United...

BIO 2000 Breaks Records: Most Successful Biotech Conference Ever!

Mar 30 2000
BOSTON Bio 2000 broke all previous records for attendance and involvement by scientists, academic researchers, company executives, patient advocates, government officials and investment experts.

BIO Opposes Bill Introduced by Senator Moynihan

Mar 30 2000
WASHINGTON (March 30, 2000) - The Biotechnology IndustryOrganization (BIO) issued the following statement in response to legislation introduced by Senator Moynihan (D-N.Y.) Wednesday advocating new...

Genentech Awarded Helix Award for Corporate Excellence

Mar 29 2000
BOSTON (March 29, 2000)Genentech, Inc. today receivedthe 2000 Helix Award during the BIO 2000 International Biotechnology Meeting and Exhibition sponsored by the Biotechnology Industry Organization...